183 related articles for article (PubMed ID: 33591941)
1. CRISPR/Cas9-mediated CysLT1R deletion reverses synaptic failure, amyloidosis and cognitive impairment in APP/PS1 mice.
Chen F; Fang S; Du Y; Ghosh A; Reed MN; Long Y; Suppiramaniam V; Tang S; Hong H
Aging (Albany NY); 2021 Feb; 13(5):6634-6661. PubMed ID: 33591941
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal CysLT1R overexpression or activation accelerates memory deficits, synaptic dysfunction, and amyloidogenesis in young APP/PS1 transgenic mice.
Fang SC; Wang JJ; Chen F; Tang SS; Mu RH; Yuan DH; Zhao JJ; Hong H; Long Y
Ann Transl Med; 2021 Oct; 9(20):1531. PubMed ID: 34790737
[TBL] [Abstract][Full Text] [Related]
3. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
[TBL] [Abstract][Full Text] [Related]
4. Blockade of adenosine A
Ji Q; Yang Y; Xiong Y; Zhang YJ; Jiang J; Zhou LP; Du XH; Wang CX; Zhu ZR
Alzheimers Res Ther; 2023 Oct; 15(1):187. PubMed ID: 37899431
[TBL] [Abstract][Full Text] [Related]
5. Novel Multitarget Directed Tacrine Hybrids as Anti-Alzheimer's Compounds Improved Synaptic Plasticity and Cognitive Impairment in APP/PS1 Transgenic Mice.
Li K; Jiang Y; Li G; Liu T; Yang Z
ACS Chem Neurosci; 2020 Dec; 11(24):4316-4328. PubMed ID: 33216529
[TBL] [Abstract][Full Text] [Related]
6. Preventive effect of genetic knockdown and pharmacological blockade of CysLT
Chen F; Ghosh A; Wu F; Tang S; Hu M; Sun H; Kong L; Hong H
Brain Behav Immun; 2017 Feb; 60():255-269. PubMed ID: 27810377
[TBL] [Abstract][Full Text] [Related]
7. Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice.
Saura CA; Chen G; Malkani S; Choi SY; Takahashi RH; Zhang D; Gouras GK; Kirkwood A; Morris RG; Shen J
J Neurosci; 2005 Jul; 25(29):6755-64. PubMed ID: 16033885
[TBL] [Abstract][Full Text] [Related]
8. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y
BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688
[TBL] [Abstract][Full Text] [Related]
9. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
[TBL] [Abstract][Full Text] [Related]
10. Muscone Ameliorates Synaptic Dysfunction and Cognitive Deficits in APP/PS1 Mice.
Liu Y; Bian H; Xu S; Shu S; Jia J; Chen J; Cao X; Bao X; Gu Y; Xia S; Yang H; Yu L; Xu Y; Zhu X
J Alzheimers Dis; 2020; 76(2):491-504. PubMed ID: 32538849
[TBL] [Abstract][Full Text] [Related]
11. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of CB
Aso E; Andrés-Benito P; Ferrer I
Biochem Pharmacol; 2018 Nov; 157():210-216. PubMed ID: 30096288
[TBL] [Abstract][Full Text] [Related]
13. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
14. DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling Pathways.
Yuan L; Zhang J; Guo JH; Holscher C; Yang JT; Wu MN; Wang ZJ; Cai HY; Han LN; Shi H; Han YF; Qi JS
J Alzheimers Dis; 2021; 80(2):695-713. PubMed ID: 33579843
[TBL] [Abstract][Full Text] [Related]
15. CysLT
Ghosh A; Chen F; Wu F; Tang SS; Hu M; Long Y; Sun HB; Kong LY; Hong H
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Feb; 73():19-30. PubMed ID: 27720931
[TBL] [Abstract][Full Text] [Related]
16. Chronic sleep deprivation exacerbates cognitive and synaptic plasticity impairments in APP/PS1 transgenic mice.
Wang C; Gao WR; Yin J; Wang ZJ; Qi JS; Cai HY; Wu MN
Behav Brain Res; 2021 Aug; 412():113400. PubMed ID: 34087256
[TBL] [Abstract][Full Text] [Related]
17. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
Jiang H; Niu F; Zheng Y; Xu Y
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
[TBL] [Abstract][Full Text] [Related]
18. Novel Phenylethanoid Glycosides Improve Hippocampal Synaptic Plasticity via the Cyclic Adenosine Monophosphate-CREB-Brain-Derived Neurotrophic Growth Factor Pathway in APP/PS1 Transgenic Mice.
Ji S; Wu Y; Zhu R; Guo D; Jiang Y; Huang L; Ma X; Yu L
Gerontology; 2023; 69(9):1065-1075. PubMed ID: 37285833
[TBL] [Abstract][Full Text] [Related]
19. The Combined Effects of Amyloidosis and Serotonin Deficiency by Tryptophan Hydroxylase-2 Knockout Impacts Viability of the APP/PS1 Mouse Model of Alzheimer's Disease.
von Linstow CU; Waider J; Bergh MS; Anzalone M; Madsen C; Nicolau AB; Wirenfeldt M; Lesch KP; Finsen B
J Alzheimers Dis; 2022; 85(3):1283-1300. PubMed ID: 34924373
[TBL] [Abstract][Full Text] [Related]
20. miR-34a deficiency in APP/PS1 mice promotes cognitive function by increasing synaptic plasticity via AMPA and NMDA receptors.
Xu Y; Chen P; Wang X; Yao J; Zhuang S
Neurosci Lett; 2018 Mar; 670():94-104. PubMed ID: 29378298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
